Spravato (Esketamine)

Experience rapid relief from treatment-resistant depression with Spravato (Esketamine) therapy, administered in a safe and supportive setting.

Innovative Treatment for Treatment-Resistant Depression

At Vivabest Psychiatry, we are proud to offer Spravato (Esketamine) therapy, an FDA-approved treatment for individuals struggling with treatment-resistant depression. This groundbreaking therapy provides rapid relief and renewed hope for those who have not found success with traditional antidepressant medications.

What is Spravato® (Esketamine)?

Spravato® is a prescription nasal spray that works differently from traditional antidepressants. It targets the brain’s NMDA receptors, which are associated with mood regulation, to provide fast-acting relief from depressive symptoms. Administered under the supervision of a licensed professional, Spravato® is a safe and effective option for eligible patients.

Benefits of Spravato® Therapy

Book an Appointment

Who is Spravato® Therapy For?

Spravato® is designed for adults diagnosed with treatment-resistant depression or those experiencing depressive symptoms associated with major depressive disorder (MDD). If traditional medications haven’t worked for you, Spravato® may be an effective alternative.

 

How Spravato® Therapy Works

Step 1
Evaluation

Our team assesses your mental health history to determine if Spravato® is the right treatment for you.

Step 2
Supervised Sessions

The nasal spray is administered in a comfortable and controlled clinical setting, ensuring safety and effectiveness.

Step 3
Comprehensive Support

Spravato® therapy is combined with ongoing counseling or therapy to enhance its benefits and support your long-term well-being.

Discover Hope with Spravato® Therapy

Break free from the cycle of treatment-resistant depression. Experience fast-acting relief with FDA-approved Spravato® (Esketamine) therapy, tailored for you.